|
Recent study findings further back the efficacy and safety of benralizumab for patients with severe asthma. Tim Harrison, MBBS, BSc, FRCP, MD, MSc, from the Respiratory Research Unit at the University of Nottingham, and colleagues conducted the ANDHI trial to extend knowledge and understanding of the efficacy and safety of benralizumab for severe eosinophilic asthma patients, including the onset of effect and additional health-related quality of life measures.
|